EWSR1 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

48 results for “EWSR1”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Not yet recruiting

EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT

24 participants · First posted Jul 10, 2026

QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma

8 participants · First posted Apr 27, 2017

Not yet recruiting

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

1,582 participants · First posted Jul 30, 2024

CIrCuLAting Dna ESr1 Gene Mutations Analysis

146 participants · First posted Oct 23, 2017

Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer

18 participants · First posted Feb 17, 2020

Study of ESR1 Mutations in Metastatic Breast Cancer

104 participants · First posted Jun 16, 2015

PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection

1,017 participants · First posted Mar 14, 2017

Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC

350 participants · First posted Aug 9, 2024

Active, not recruiting

Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer

18 participants · First posted Nov 15, 2024

Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation

60 participants · First posted Jun 4, 2018

Page 1 of 3